Recombinant activated factor VII for refractory bleeding after cardiac surgery—A retrospective analysis of safety and efficacy-Reference-Cited by-同舟云学术

Recombinant activated factor VII for refractory bleeding after cardiac surgery—A retrospective analysis of safety and efficacy

Published:2005-10 Issue:10 Volume:33 Page:2241-2246
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

von Heymann Christian,Redlich Uwe,Jain Uday,Kastrup Marc,Schroeder Torsten,Sander Michael,Grosse Joachim,Ziemer Sabine,Koscielny Juergen,Konertz Wolfgang F.,Wernecke Klaus-Dieter,Spies Claudia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference23 articles.

1. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations

2. Reexploration for Hemorrhage Following Coronary Artery Bypass GraftingIncidence and Risk Factors

3. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation

4. Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding;Anesthesiology;2023-05-08

2. Comparison of Prothrombin Complex Concentrate with Activated Factor VII Use for Bleeding Following Cardiopulmonary Bypass in Children;World Journal for Pediatric and Congenital Heart Surgery;2023-03-15

3. Outcomes of 4-factor Prothrombin Complex Concentrate in Patients With Liver Disease and Nonvitamin K Antagonist-Related Coagulopathy: A Retrospective Study;Clinical and Applied Thrombosis/Hemostasis;2023-01

4. Factor eight inhibiting bypass activity for refractory bleeding in acute type A aortic dissection repair: A propensity‐matched analysis;Transfusion;2022-09-21

5. Impact of Early, Low-Dose Factor VIIa on Subsequent Transfusions and Length of Stay in Cardiac Surgery;Journal of Cardiothoracic and Vascular Anesthesia;2022-01